Martínez Carmona, MarinaGun´ko, YuriiVallet Regí, María Dulce Nombre2023-06-172023-06-172018-04-232079-499110.3390/nano8040268https://hdl.handle.net/20.500.14352/12059RESEARCHER ID N-3992-2014 (Marina Martínez Carmona) ORCID 0000-0002-2026-6266 (Marina Martínez Carmona) RESEARCHER ID M-3378-2014 (María Vallet Regí) ORCID 0000-0002-6104-4889 (María Vallet Regí)In the last two decades, zinc oxide (ZnO) semiconductor Quantum dots (QDs) have been shown to have fantastic luminescent properties, which together with their low-cost, low-toxicity and biocompatibility have turned these nanomaterials into one of the main candidates for bio-imaging. The discovery of other desirable traits such as their ability to produce destructive reactive oxygen species (ROS), high catalytic efficiency, strong adsorption capability and high isoelectric point, also make them promising nanomaterials for therapeutic and diagnostic functions. Herein, we review the recent progress on the use of ZnO based nanoplatforms in drug delivery and theranostic in several diseases such as bacterial infection and cancer.engAtribución 3.0 Españahttps://creativecommons.org/licenses/by/3.0/es/ZnO Nanostructures for Drug Delivery and Theranostic Applicationsjournal articlehttp://www.mdpi.com/2079-4991/8/4/268http://www.ucm.es/valletregigroupopen access66546615.46ZnO nanoparticlesQuantum dotsTheranosticDrug deliveryAnti-tumourDiabetes treatmentanti-inflammationantibacterialantifungalwound healingMaterialesQuímica inorgánica (Farmacia)3312 Tecnología de Materiales